Published in Med Sci Monit on January 12, 2015
Severe airflow obstruction in a patient with ulcerative colitis and toxic epidermal necrolysis: A case report. Exp Ther Med (2015) 0.78
Drug induced exfoliative dermatitis: state of the art. Clin Mol Allergy (2016) 0.76
Evaluation of the patients diagnosed with Stevens Johnson syndrome and toxic epidermal necrolysis: a single center experience. Turk Pediatri Ars (2016) 0.75
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature (2005) 10.10
Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med (1995) 7.21
Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol (1956) 6.70
Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature (2011) 5.41
Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell (2007) 4.66
The vitamin A content and toxicity of bear and seal liver. Biochem J (1943) 3.75
Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol (2007) 3.58
Overview of retinoid metabolism and function. J Neurobiol (2006) 3.19
Possible association between isotretinoin and inflammatory bowel disease. Am J Gastroenterol (2006) 2.97
Allopurinol hypersensitivity syndrome: a review. Ann Pharmacother (1993) 2.69
Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med (2008) 2.66
The acute and chronic toxic effects of vitamin A. Am J Clin Nutr (2006) 2.57
Studies on the mode of action of excess of vitamin A. 5. The effect of vitamin A on the stability of the erythrocyte membrane. Biochem J (1962) 2.41
Isotretinoin use and the risk of inflammatory bowel disease: a case-control study. Am J Gastroenterol (2010) 2.10
Mucosal disease series. Number IV. Erythema multiforme. Oral Dis (2005) 2.07
Toxic epidermal necrolysis. J Am Acad Dermatol (2007) 1.89
Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin. Blood (2010) 1.85
Antimalarial drugs in the treatment of rheumatological diseases. Br J Rheumatol (1997) 1.84
Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4. Proc Natl Acad Sci U S A (1994) 1.79
Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol (2005) 1.78
Outbreak of Stevens-Johnson syndrome/toxic epidermal necrolysis associated with mebendazole and metronidazole use among Filipino laborers in Taiwan. Am J Public Health (2003) 1.65
Discovery of novel targets of quinoline drugs in the human purine binding proteome. Mol Pharmacol (2002) 1.59
Signaling by vitamin A and retinol-binding protein regulates gene expression to inhibit insulin responses. Proc Natl Acad Sci U S A (2011) 1.58
From carrot to clinic: an overview of the retinoic acid signaling pathway. Cell Mol Life Sci (2010) 1.57
Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Am J Clin Dermatol (2001) 1.48
Burn center care for patients with toxic epidermal necrolysis. J Am Coll Surg (1995) 1.48
Between death and survival: retinoic acid in regulation of apoptosis. Annu Rev Nutr (2010) 1.43
Do tetracyclines and erythromycin exert anti-acne effects by inhibition of P450-mediated degradation of retinoic acid? Exp Dermatol (2014) 1.41
Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J (2002) 1.35
Retinoic acid: its biosynthesis and metabolism. Prog Nucleic Acid Res Mol Biol (1999) 1.30
Retinoic acid metabolism and mechanism of action: a review. Curr Drug Metab (2003) 1.29
Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Am J Pathol (2003) 1.14
A relationship between vitamin A metabolism and cortisone. Endocrinology (1955) 1.14
Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions. Drug Saf (2003) 1.12
A distinct pathway of cell-mediated apoptosis initiated by granulysin. J Immunol (2001) 1.11
A role of the mitochondrial apoptosis-inducing factor in granulysin-induced apoptosis. J Immunol (2001) 1.11
Granulysin induces cathepsin B release from lysosomes of target tumor cells to attack mitochondria through processing of bid leading to Necroptosis. J Immunol (2009) 1.10
Protein-based therapeutic approaches targeting death receptors. Cell Death Differ (2003) 1.08
Vancomycin-induced leukocytoclastic vasculitis. Pharmacotherapy (2009) 1.07
Optimizing current treatment of gout. Nat Rev Rheumatol (2014) 1.01
Generalized peeling skin syndrome: Case report and review of the literature. Dermatol Online J (2010) 1.01
Hypervitaminosis A: a liver lover's lament. Hepatology (1988) 1.01
Sulfonamide hypersensitivity. Immunol Allergy Clin North Am (2004) 0.99
Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases. J Dermatol Sci (2008) 0.96
Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature. Am J Health Syst Pharm (2010) 0.96
Leukotrienes as mediators of airway obstruction. Am J Respir Crit Care Med (1998) 0.95
Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes. Intensive Care Med (2009) 0.95
The mechanism of retinol-induced irritation and its application to anti-irritant development. Toxicol Lett (2003) 0.95
Retinoic acid increases the expression of p53 and proapoptotic caspases and sensitizes keratinocytes to apoptosis: a possible explanation for tumor preventive action of retinoids. Cancer Res (2004) 0.94
Induction of granulysin in CD8+ T cells by IL-21 and IL-15 is suppressed by human immunodeficiency virus-1. J Leukoc Biol (2009) 0.94
Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: experience with 41 cases and a hypothesis regarding pathogenesis. Ann Allergy (1994) 0.92
Stevens-Johnson Syndrome and cholestatic hepatitis. Dig Dis Sci (2001) 0.92
Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome. Ann Intern Med (2009) 0.90
Interventions for toxic epidermal necrolysis. Cochrane Database Syst Rev (2002) 0.90
Periconceptional vitamin A use: how much is teratogenic? Reprod Toxicol (1998) 0.89
Postprandial plasma retinyl ester response is greater in older subjects compared with younger subjects. Evidence for delayed plasma clearance of intestinal lipoproteins. J Clin Invest (1990) 0.89
Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis. J Am Acad Dermatol (1999) 0.88
Vitamin E: inhibition of retinol-induced hemolysis and membrane-stabilizing behavior. J Biol Chem (1992) 0.87
Retinoic acid receptors regulate expression of retinoic acid 4-hydroxylase that specifically inactivates all-trans retinoic acid in human keratinocyte HaCaT cells. J Invest Dermatol (1998) 0.85
Early mitochondrial alterations in ATRA-induced cell death. Cell Death Differ (2006) 0.85
Stevens-Johnson syndrome after immunization with smallpox, anthrax, and tetanus vaccines. Mayo Clin Proc (2004) 0.84
Ibuprofen-induced hypersensitivity syndrome. Transl Res (2010) 0.83
Gout and vitamin A intoxication: is there a connection? Semin Arthritis Rheum (1991) 0.82
Ichthyosiform dermatosis with superficial blister formation and peeling: evidence for a desmosomal anomaly and altered epidermal vitamin A metabolism. J Am Acad Dermatol (1996) 0.81
Preparation and properties of retinal-oxidizing enzyme from rat intestinal mucosa. J Biol Chem (1970) 0.81
The effect of glucocorticosteroids on serum, liver, and lung vitamin A and retinyl ester concentrations. J Pediatr Gastroenterol Nutr (1991) 0.80
Unique property of some synthetic retinoids: activation of the aryl hydrocarbon receptor pathway. Mol Pharmacol (2002) 0.79
Antiepileptic drugs alter endogenous retinoid concentrations: a possible mechanism of teratogenesis of anticonvulsant therapy. Life Sci (1995) 0.79
Xanthine oxidase catalyzes the synthesis of retinoic acid. J Enzyme Inhib (2001) 0.79
Liver disease and protein needs. Annu Rev Nutr (1982) 0.78
IL-15 modulates the effect of retinoic acid, promoting inflammation rather than oral tolerance to dietary antigens. Expert Rev Gastroenterol Hepatol (2011) 0.78
Fluconazole alters CYP26 gene expression in mouse embryos. Reprod Toxicol (2009) 0.78
Retinoic acid up-regulates myeloid ICAM-3 expression and function in a cell-specific fashion--evidence for retinoid signaling pathways in the mast cell lineage. J Leukoc Biol (2001) 0.78
Phenytoin-induced toxic cholestatic hepatitis in a patient with skin lesions: case report. South Med J (2003) 0.77
Decline in plasma retinol in unconjugated hyperbilirubinemia treated with bilirubin adsorption using an anion-exchange resin. J Nutr Sci Vitaminol (Tokyo) (1998) 0.77
Selective upregulation of fibroblast Fas ligand expression, and prolongation of Fas/Fas ligand-mediated skin allograft survival, by retinoic acid: the skin as a retinoide-inducible immune privilege site. J Invest Dermatol (2000) 0.77
Retinoids induce apoptosis in cultured keratinocytes. Br J Dermatol (2000) 0.77
The multifaceted granulysin. Blood (2010) 0.77
Inhibition of DNA and RNA synthesis in lymphocyte cultures by rod outer segments and its counteraction by vitamin E and other antioxidants. Invest Ophthalmol Vis Sci (1980) 0.77
cDNA cloning and expression of rat leukotriene C(4) synthase: elevated expression in rat basophilic leukemia-1 cells after treatment with retinoic acid. Prostaglandins Leukot Essent Fatty Acids (2002) 0.76
Topical tretinoin increases dermal mast cells, induces epidermal mast cell growth factor (c-kit ligand) and modulates its distribution in hairless mice. Arch Dermatol Res (1996) 0.76
Inhibition by dexamethasone of retinoic acid-induced enhancement of leukotriene C4 synthesis in rat basophilic leukemia-1 cells. Am J Respir Cell Mol Biol (1994) 0.76
Fatal toxic epidermal necrolysis associated with etretinate. BMJ (1992) 0.76
36-year-old man with productive cough and diffuse rash. Mayo Clin Proc (2006) 0.76
Blistering, erosions and scarring in a patient on etretinate. Br J Dermatol (1989) 0.76